Iterum Therapeutics plc (ITRM)

Iterum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.03	24.13	6.07	21.09	27.45	14.51
Short-Term Investments	-	-	17.86	39.71	53.94	2.36
Cash & Short-Term Investments	13.03	24.13	23.93	60.8	81.38	16.87
Cash Growth	11.17%	0.81%	-60.64%	-25.29%	382.46%	183.97%
Other Receivables	0.08	0.07	0.23	0.42	1.21	3.74
Receivables	0.08	0.07	0.23	0.42	1.21	3.74
Prepaid Expenses	0.84	0.53	1.43	1.22	0.68	0.8
Restricted Cash	-	-	-	-	-	0.06
Other Current Assets	-	0.07	-	-	-	-
Total Current Assets	14.89	24.79	25.6	62.44	83.27	21.47
Property, Plant & Equipment	0.01	0.02	0.6	1.84	3.83	5.68
Other Intangible Assets	19.06	19.75	-	1.72	3.44	-
Other Long-Term Assets	0.05	0.04	0.06	0.83	0.98	5.64
Total Assets	34.01	44.6	26.26	66.83	91.51	32.79
Accounts Payable	1.19	0.25	5	2.77	0.88	0.82
Accrued Expenses	3.95	2.65	7.76	4.35	1.17	1.83
Short-Term Debt	-	14.46	-	-	-	-
Current Portion of Long-Term Debt	0.19	-	-	-	1.63	6.49
Current Portion of Leases	-	0.07	0.37	0.33	0.46	0.57
Current Income Taxes Payable	0.01	-	-	-	0.22	0.1
Other Current Liabilities	0.2	0.17	0.4	1.61	8.59	31.89
Total Current Liabilities	5.53	17.61	13.52	9.06	12.94	41.7
Long-Term Debt	32.37	31.07	18.96	28.47	24.9	35.85
Long-Term Leases	-	-	0.19	1.3	3.44	5.17
Other Long-Term Liabilities	-	-	-	-	-	0.63
Total Liabilities	37.9	48.68	32.66	38.83	41.28	83.35
Common Stock	0.42	0.32	0.14	0.13	0.12	0.49
Additional Paid-In Capital	493.16	481.68	454.76	451.15	428.61	235.88
Retained Earnings	-497.47	-486.07	-461.3	-422.93	-378.49	-286.93
Comprehensive Income & Other	-	-	0	-0.35	-	-
Total Common Equity	-3.89	-4.08	-6.4	28	50.23	-50.56
Shareholders' Equity	-3.89	-4.08	-6.4	28	50.23	-50.56
Total Liabilities & Equity	34.01	44.6	26.26	66.83	91.51	32.79
Total Debt	32.56	45.6	19.51	30.1	30.43	48.08
Net Cash (Debt)	-19.53	-21.48	4.42	30.7	50.96	-31.22
Net Cash Growth	-	-	-85.60%	-39.75%	-	-
Net Cash Per Share	-0.65	-1.09	0.34	2.51	4.68	-19.50
Filing Date Shares Outstanding	44.66	34.58	16.43	12.71	12.19	11.77
Total Common Shares Outstanding	42.13	31.53	13.5	12.6	12.19	3.3
Working Capital	9.36	7.18	12.08	53.38	70.33	-20.23
Book Value Per Share	-0.09	-0.13	-0.47	2.22	4.12	-15.34
Tangible Book Value	-22.95	-23.83	-6.4	26.28	46.8	-50.56
Tangible Book Value Per Share	-0.54	-0.76	-0.47	2.09	3.84	-15.34
Machinery	0.22	0.22	0.22	0.21	0.23	0.34
Leasehold Improvements	0.1	0.15	0.15	0.15	0.15	0.59

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q